Current status and analysis of registered specialty Respiratory drug clinical trial institutions in China
OBJECTIVE To understand the current registration status of specialty Respiratory drug clinical trial institutions and their principal investigators(PI)in China,to act as a reference for the development of a specialty Respiratory clinical research network in China.METHODS Statistical analysis of the status of registered specialty Respiratory clinical trial institutions was performed through the drug clinical trial institution registration management information platform and the drug clinical trials regis-tration and information publicity platform.The search period was from the date that the registration management platform was built to March 9,2023 and from the date that the publicity platform was built to December 31,2022.RESULTS As of March 9,2023,there were a total of 771 registered specialty Respiratory institutions in China,distributed in 31 first-level administrative regions,with 3 133 specialty Respiratory PI.Guangdong,Jiangsu,Henan and other provinces ranked among the top 9 provinces in terms of the number of registered specialty Respiratory institutions,together accounted for 57.1%of the country's total.The regional distribution of specialty Respiratory PI was positively correlated with the distribution of registered specialty Respiratory institutions.87.0%of the registered specialty Respiratory institutions were third-A hospitals,and 93.7%of specialty Respiratory PI were concentrated in third-A hospitals.As of December 31,2022,among registered specialty Respiratory institutions,the top 10 provinces in terms of the number of specialty Respiratory clinical trial leader units,accounted for 75.7%of the country's Respi-ratory clinical trials.CONCLUSION Specialty Respiratory institutions and PI resources in China face the problems of unbal-anced integration,horizontally and vertically.Disadvantaged regions and institutions need to be encouraged to fully develop,to lay the foundation for building a specialty Respiratory clinical research network.